EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of Cancer Stem-like Cells by Curcumin and Other Polyphenol Derivatives in MDA-MB-231 TNBC Cells

Maria Ros iD, Gerard Riesco-Llach iD, Emma Polonio-Alcalá iD, Pere Miquel Morla-Barcelo iD, Santiago Ruiz-Martínez, Lidia Feliu iD, Marta Planas iD, Teresa Puig iD

International Journal of Molecular Sciences · 06.07.2024 · 25 (13) · 7446

DOI: 10.3390/ijms25137446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.07.2024. Verfasst von Maria Ros und 7 weiteren Autor:innen. Beteiligte Einrichtung: New Therapeutic Targets Laboratory (TargetsLab)-Oncology Unit, Department of Medical Sciences, Faculty of Medicine, University of Girona, 17003 Giron…. Hauptthemen laut MEDLINE: Curcumin, Neoplastic Stem Cells, Triple Negative Breast Neoplasms, Polyphenols. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Estatal de Investigación, PLEC2021-007523/AEI/10.13039/501100011033, European Union—NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) accounts for 15% of all breast cancers and is highly aggressive. Despite an initial positive response to chemotherapy, most patients experience rapid disease progression leading to relapse and metastasis. This is attributed to the presence of breast cancer stem cells (BCSCs) within the tumor, which are characterized by self-renewal, pluripotency, and resistance mechanisms. Targeting BCSCs has become critical as conventional therapies fail to eradicate them due to a lack of specific targets. Curcumin, a polyphenol derived from turmeric (Curcuma longa), exhibits anticancer effects against breast cancer cells and BCSCs. The use of curcumin derivatives has been suggested as an approach to overcome the bioavailability and solubility problems of curcumin in humans, thereby increasing its anticancer effects. The aim of this study was to evaluate the cellular and molecular effects of six synthetic compounds derived from the natural polyphenol epigallocatechin gallate (EGCG) (TL1, TL2) and curcumin derivatives (TL3, TL4, TL5, and TL6) on a TNBC mesenchymal stem-like cell line. The activity of the compounds against BCSCs was also determined by a mammosphere inhibition assay and studying different BCSC markers by Western blotting. Finally, a drug combination assay was performed with the most promising compounds to evaluate their potential synergistic effects with the chemotherapeutic agents doxorubicin, cisplatin, and paclitaxel. The results showed that compounds exhibited specific cytotoxicity against the TNBC cell line and BCSCs. Interestingly, the combination of the curcumin derivative TL3 with doxorubicin and cisplatin displayed a synergistic effect in TNBC cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminNeoplastic Stem CellsTriple Negative Breast NeoplasmsPolyphenolsHumansCell Line, TumorFemaleAntineoplastic AgentsCell ProliferationCatechin

Stichwörter der Autor:innen

cancer stem cellscurcuminpolyphenolstriple-negative breast cancer

Substanzen

CurcuminPolyphenolsAntineoplastic AgentsCatechinepigallocatechin gallate

Autor:innen und Institutionen

  • New Therapeutic Targets Laboratory (TargetsLab)-Oncology Unit, Department of Medical Sciences, Faculty of Medicine, University of Girona, 17003 Girona, Spain.
  • Laboratori d'Innovació en Processos i Productes de Síntesi Orgànica (LIPPSO), Department of Chemistry, University of Girona, 17003 Girona, Spain.
  • Grupo Multidisciplinar de Oncología Traslacional, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, 07122 Palma, Spain.
  • Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, Sahlgrenska Center for Cancer Research, University of Gothenburg, 405 30 Gothenburg, Sweden.

ORCID-Profile: Maria Ros, Gerard Riesco-Llach, Emma Polonio-Alcalá, Pere Miquel Morla-Barcelo, Lidia Feliu, Marta Planas, Teresa Puig

Förderung

  • Agencia Estatal de Investigación
  • PLEC2021-007523/AEI/10.13039/501100011033
  • European Union—NextGenerationEU
  • Instituto de Salud Carlos III
  • European Union ERDF/ESF

Zitieren

APA

Ros, M., Riesco-Llach, G., Polonio-Alcalá, E., Morla-Barcelo, P. M., Ruiz-Martínez, S., Feliu, L., Planas, M., & Puig, T. (2024). Inhibition of Cancer Stem-like Cells by Curcumin and Other Polyphenol Derivatives in MDA-MB-231 TNBC Cells. International Journal of Molecular Sciences, 25(13), 7446. https://doi.org/10.3390/ijms25137446

Vancouver

Ros M, Riesco-Llach G, Polonio-Alcalá E, Morla-Barcelo PM, Ruiz-Martínez S, Feliu L, et al. Inhibition of Cancer Stem-like Cells by Curcumin and Other Polyphenol Derivatives in MDA-MB-231 TNBC Cells. International Journal of Molecular Sciences. 2024;25(13):7446. doi:10.3390/ijms25137446

BibTeX
@article{Ros2024,
  author = {Ros, Maria and Riesco-Llach, Gerard and Polonio-Alcalá, Emma and Morla-Barcelo, Pere Miquel and Ruiz-Martínez, Santiago and Feliu, Lidia and Planas, Marta and Puig, Teresa},
  title = {Inhibition of Cancer Stem-like Cells by Curcumin and Other Polyphenol Derivatives in MDA-MB-231 TNBC Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {13},
  pages = {7446},
  doi = {10.3390/ijms25137446}
}
Kostenlos starten →